ClinicalTrials.gg
Not yet recruitingNCT07923331EpisiotomyUpdated Nov 6, 2026

Effect of a Novel Episiotomy Repair Simulator on Midwifery Students' Self-Efficacy and Anxiety

An interventional study of Deney Grubu - Intervention Name and Kontrol Grubu - Intervention Name in Episiotomy Repair Training, sponsored by Sakarya University. Not yet recruiting. Open to female participants aged 18 Years to 45 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-11-06.

Sponsored by Sakarya University · Not applicable, Interventional, and Other

Updated Nov 6, 2026Newly registeredGo to Updates ↓
Phase
Not applicable
Study type
Interventional
Enrollment
106
Allocation
Randomized
Ages
18 Years to 45 Years
Sex
Female
01

Study summary

This randomized controlled study aims to evaluate the effects of a newly developed episiotomy repair simulator using biological tissue and simulated active bleeding on midwifery students' self-efficacy and anxiety levels.

Midwifery students enrolled in the Normal Birth and Postpartum Period course at Sakarya University will be randomly assigned to one of two groups. Both groups will receive the same theoretical training on episiotomy and its repair. Students in the intervention group will practice using the newly developed simulator, which provides a restricted working area and simulated active bleeding conditions. Students in the control group will practice using the traditional beef tongue model.

Students' episiotomy self-efficacy and state anxiety levels will be assessed before and after the training using validated measurement tools. The study aims to determine whether the newly developed simulator offers educational benefits compared with the traditional training method.

02

Conditions studied

  • Episiotomy Repair Training
03

In context

Lead sponsor

Sakarya University is the lead sponsor of 190 studies on the registry; 53 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 45 Years
Sexes eligible
Female
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Being enrolled in the Midwifery Department at Sakarya University.
  • Being enrolled in the Normal Birth and Postpartum Period course during the 2026-2027 fall semester.
  • Voluntarily agreeing to participate in the study and providing .

Exclusion criteria

Exclusion Criteria:

  • Having previously taken and failed the Normal Birth and Postpartum Period course.
  • Being absent from the episiotomy laboratory training session.
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Phase
Not applicable
Primary purpose
Other
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
106 participants (estimated)

Study arms

  • Experimental
    Biological Tissue and Active Bleeding-Assisted Episiotomy Repair Simulation

    Participants in this group will receive 50 minutes of theoretical training on episiotomy and its repair, followed by practical training using the newly developed biological tissue and active bleeding-assisted episiotomy repair simulator. The simulator provides a restricted working area, biological tissue for suturing, and simulated active bleeding conditions. Participants will complete self-efficacy and state anxiety assessments before and after the training.

    Other: Deney Grubu - Intervention Name

  • Active comparator
    Traditional Beef Tongue Episiotomy Training

    Participants in this group will receive the same 50-minute theoretical training on episiotomy and its repair, followed by practical training using the traditional beef tongue model routinely used in midwifery education. Each participant will have the opportunity to practice episiotomy and repair techniques under researcher supervision. Self-efficacy and state anxiety will be assessed before and after the training.

    Other: Kontrol Grubu - Intervention Name

Interventions

  • OtherDeney Grubu - Intervention Name

    Biological Tissue and Active Bleeding-Assisted Episiotomy Repair Simulation

  • OtherKontrol Grubu - Intervention Name

    Traditional Beef Tongue Episiotomy Repair Training

06

What researchers measure

Primary outcomes

  1. Change in Episiotomy Self-Efficacy Scale Score

    Episiotomy self-efficacy will be assessed using the Episiotomy Self-Efficacy Scale developed by Yolcu et al. (2025). The scale consists of 17 items across four dimensions: cognitive (5 items), affective (5 items), motivation (3 items), and psychomotor (4 items). Each item is rated on a 5-point Likert scale, with total scores ranging from 17 to 85. Higher scores indicate greater episiotomy self-efficacy. Changes in total scores from before to after training will be compared between the intervention and control groups.

    Time frame: Immediately before and immediately after the training session (same day).

  2. Change in State Anxiety Inventory (STAI-State) Score

    State anxiety will be assessed using the State Anxiety Inventory (STAI-State), which consists of 20 items measuring participants' anxiety at the time of assessment. Total scores range from 20 to 80, with higher scores indicating greater state anxiety. Changes in total scores from before to after training will be compared between the intervention and control groups.

    Time frame: Immediately before and immediately after the training session (same day).

07

Study locations

No study locations are listed for this record.

08

References and documents

Individual participant data

Plan to share: No — Individual participant data will not be publicly shared due to participant confidentiality and data protection considerations. The data collected in this study will be used solely for the purposes of the research and will be securely stored by the research team.

No publications or documents are linked to this record.

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Start is estimated for Nov 2026; primary completion for Dec 2026, 0 months later.

How these figures are worked out, and which studies are left out of them.

Registered
Nov 2, 2026
First posted
Nov 6, 2026
StartEst.
Nov 19, 2026
Primary completionEst.
Dec 10, 2026
CompletionEst.
Jan 15, 2027
Last update
Nov 6, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Registered
First appeared on the registry. No changes since
Nov 6, 2026
Show all 1 update
  1. Nov 6, 2026
    First appeared on the registry

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07923331
Lead sponsor
Sakarya University
Responsible party
Yasemin Hamlaci Baskaya (Associate Professor, Principal Investigator, Sakarya University) — Principal investigator
First posted
Nov 6, 2026
Start date
Nov 19, 2026 (estimated)
Primary completion
Dec 10, 2026 (estimated)
Completion
Jan 15, 2027 (estimated)
Last update
Nov 6, 2026

Study contacts

Busra Y Yolcu, PhD
Contact
busrayolcu@sakarya.edu.tr
05350364594

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Nov 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion